Robert MacLeod

Robert MacLeod

Company: Flamingo Therapeutics

Job title: CSO

Seminars:

Therapeutic Targeting of LncRNAs with Next Generation Antisense Oligonucleotides in Cancer 11:00 am

Discussing the potential of targeting lncRNAs with next generation antisense drug for cancer The technology also enables the rapid target validation of candidate lncRNAs in vitro and in vivo with the FLAME discovery engine Identification and selection of clinical candidate Malat1rx for the treatment of cancerRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.